Cargando…

Shark Attack: Introducing the 2023 Technology and Heart Failure Therapeutics Shark Tank Edition of JACC: Basic to Translational Science

Detalles Bibliográficos
Autor principal:	Mann, Douglas L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Focus Issue: Technology and Heart Failure Therapeutics 2023 Shark Tank
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10149649/ https://www.ncbi.nlm.nih.gov/pubmed/37138807 http://dx.doi.org/10.1016/j.jacbts.2023.03.006

Ejemplares similares

Making Science Fun Again: Technology and Heart Failure Therapeutics 2022 Shark Tank
por: Mann, Douglas L.
Publicado: (2022)

Highlights of Innovation and Technologies and Heart Failure Therapeutics: THT 2023
por: Burkhoff, Daniel
Publicado: (2023)

Subcutaneously Insertable Cardiac Monitor for Atrial Fibrillation and HF Using ECG and Phonocardiography as Biomarkers
por: Bang, Jaeson
Publicado: (2023)

A Novel Multisensor Device for Absolute Intracardiac Pressure Measurement, Detection, and Management of Heart Failure
por: Mace, Matthew Ian
Publicado: (2023)

Minimally Invasive Fully Implantable Cardiac Support System to Restore Left Ventricular Function in Heart Failure
por: Schnegelsberg, Patrick N.J., et al.
Publicado: (2023)

Prolonged Low-Intensity Ultrasound Delivery as Potential Kidneys Treatment for Acutely Decompensated Heart Failure Patients
por: Rousso, Benny, et al.
Publicado: (2023)

Novel Intranasal Loop Diuretic
por: Esque, Benjamin, et al.
Publicado: (2023)

A Subcutaneous Multiparameter Sensor With Integrated Interstitial Fluid Pressure Measurement for Remote Heart Failure Monitoring
por: Rothman, Alexander M.K., et al.
Publicado: (2023)

Highlighting the Unique Challenges Presented by Device Trials in Heart Failure
por: Mann, Douglas L.
Publicado: (2022)

Novel Noninvasive Biosensors and Artificial Intelligence for Optimized Heart Failure Management
por: Neill, Luke, et al.
Publicado: (2022)

Cardiac Pulmonary Nerve Stimulation (CPNS(TM)): A Novel Treatment for Acute Decompensated Heart Failure
por: Goedeke, Steve, et al.
Publicado: (2022)

Technology and Heart Failure Therapeutics (THT2022): A Glimpse Into the Future of Devices and Novel Therapies for Heart Failure
por: Burkhoff, Daniel, et al.
Publicado: (2022)

Audicor Remote Patient Monitoring: FDA Breakthrough Device and Technology for Heart Failure Management
por: Fudim, Marat, et al.
Publicado: (2022)

Splanchnic Nerve Ablation for Volume Management in Heart Failure
por: Fudim, Marat, et al.
Publicado: (2022)

Wireless Powered and Water-Proof Mechanical Circulatory Support Device for Ambulatory Class III Heart Failure
por: Miller, Leslie, et al.
Publicado: (2022)

Synchronized Diaphragmatic Stimulation for the Treatment of Symptomatic Heart Failure: A Novel Implantable Therapy Concept
por: Fudim, Marat, et al.
Publicado: (2022)

Novel IVC Doraya Catheter Provides Congestion Relief in Patients With Acute Heart Failure
por: Zymliński, Robert, et al.
Publicado: (2022)

Trends in global shark attacks
por: Midway, Stephen R., et al.
Publicado: (2019)

Down Under: Shark attack
por: Struik, Arianne
Publicado: (2020)

Introducing JACC: Basic to Translational Science: Why Now?
por: Mann, Douglas L., et al.
Publicado: (2016)

Prevalence of left ventricular dysfunction in a UK community sample of very old people: the Newcastle 85+ study
por: Yousaf, Fahad, et al.
Publicado: (2012)

Effect of Left Ventricular Assist Device Implantation and Heart Transplantation on Habitual Physical Activity and Quality of Life()
por: Jakovljevic, Djordje G., et al.
Publicado: (2014)

The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective
por: Griffiths, A, et al.
Publicado: (2014)

Referral for Specialist Follow-up and Its Association With Post-discharge Mortality Among Patients With Systolic Heart Failure (from the National Heart Failure Audit for England and Wales)
por: Emdin, Connor A., et al.
Publicado: (2017)

Obesity paradox in heart failure patients – Female gender characteristics-KAMC-single center experience
por: Khaled, Sheeren, et al.
Publicado: (2017)

Clinical and laboratory characteristics of short-term mortality in Egyptian patients with acute heart failure
por: Abdellah, Ahmad Tageldien, et al.
Publicado: (2017)

Effect of cardiac rehabilitation on cardiovascular risk factors in chronic heart failure patients
por: Mohammed, Haitham Galal, et al.
Publicado: (2018)

Continuous infusion of furosemide versus intermittent boluses in acute decompensated heart failure: Effect on thoracic fluid content
por: Ragab, Dalia, et al.
Publicado: (2018)

Myocardial performance index as an echocardiographic predictor of early in-hospital heart failure during first acute anterior ST-elevation myocardial infarction
por: Abuomara, Hossamaldin Zaki Alsayed, et al.
Publicado: (2018)

Assessment of right ventricular function by echocardiography in patients with chronic heart failure
por: William, Viola, et al.
Publicado: (2018)

Prevalence of P wave dispersion and interatrial block in patients with systolic heart failure and their relationship with functional status, hospitalization and one year mortality
por: Abdellah, Ahmed Tageldien, et al.
Publicado: (2018)

Destination Therapy with Left Ventricular Assist Devices in Non-transplant Centres: The Time is Right
por: Bayes-Genis, Antoni, et al.
Publicado: (2020)

Interatrial Shunting for Treating Acute and Chronic Left Heart Failure
por: Guimaraes, Leonardo, et al.
Publicado: (2020)

Manipulating angiotensin metabolism with angiotensin converting enzyme 2 (ACE2) in heart failure
por: Patel, Vaibhav B., et al.
Publicado: (2012)

Arrhythmogenic Cardiomyopathy: A Disease or Merely a Phenotype?
por: Protonotarios, Alexandros, et al.
Publicado: (2020)

Heart Failure Treatment by Device
por: Bayés-Genis, Antoni
Publicado: (2020)

Asymptomatic Left Ventricle Systolic Dysfunction
por: Sara, Jaskanwal D, et al.
Publicado: (2020)

Contemporary Management of Secondary Mitral Regurgitation
por: Goel, Kashish, et al.
Publicado: (2020)

Novel Pharmacological Treatment of Patients with Type 2 Diabetes and Cardiovascular Disease: What Cardiologists and Diabetologists Should Know
por: Martínez, Felipe
Publicado: (2021)

Levosimendan in Europe and China: An Appraisal of Evidence and Context
por: Kong, Xiangqing, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2pem28e1l5u64dcku7fclhh6l3